Report: Higher-Rated MA Plans Are Less Available in Vulnerable Counties
Disadvantaged counties are less likely to have Medicare Advantage plans with 4.5 stars or higher and more likely to have plans with 3.5 stars or lower, a new study found.
Oncolytic immunotherapy startup BeneVir gets $3M
BeneVir's cancer vaccines are engineered to incite an immune response, as well as hide from the immune system - so as to have a prolonged anti-cancer effect.
presented by
Why Your Patients Are Leaving and How to Stop It
Patient expectations continue to evolve, and healthcare practices that fail to adapt risk more than just revenue—they risk losing trust.
Ovarian cancer biotech Cynvec inches forward in $10 million round
New York-based biotech company, Cynvec, is currently raising capital to aid in the development of a vaccine designed to treat ovarian cancer.
Health app developers: This is what’s turning your users off
The most damning insight comes from the question of why they stopped using the apps they downloaded.
NYU Medical School adds big data to course requirements
The project is funded in part by an effort of the American Medical Association to update what and how medical students are taught. Students can use tools provided by the project to look at quality measures for things like heart failure, diabetes, smoking, etc.
Why do screams scare us and trigger a response differently than other loud noises?
When you hear someone scream, a very specific part of your brain gets activated.
presented by
How PDPM Optimization Improves Facility Financial Performance
Transitioning to PDPM models significantly shifted the healthcare industry. By replacing the RUG system, healthcare providers cut waste and more accurately reflect the care each patient received.
Johnson & Johnson is creating a bioethics panel to evaluate “compassionate use” drug availability
Johnson & Johnson will create a bioethics panel to evaluate when unapproved drugs still in testing phase should be made available to patients who are terminally ill.
How long does it take to become a doctor? Some medical schools shaving off a year of training
For Travis Hill, it was an offer too good to refuse. Last year when the 30-year-old neuroscientist was admitted to a new program at New York University that would allow him to complete medical school in only three years and guarantee him a spot in its neurosurgery residency, he seized it. Not only would Hill […]
Biotech accelerator BioMotiv, NYU unveil a new spinoff for inflammatory disease treatments
A biotech accelerator launched as part of a $250 million drug discovery initiative spearheaded by Cleveland’s University Hospitals has spun off its first company to develop promising technology for treating inflammatory diseases. Orca Pharmaceuticals is the first company announced by BioMotiv, the for-profit accelerator associated with the Harrington Discovery Project at UH. BioMotiv in- licenses […]